Isoniazid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 7 USDMF, 5 CEP/COS, 1 JDMF, 2 EU WC, 5 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

154 FDF Dossiers, 61 FDA Orange Book, 19 Europe, 3 Canada, 1 Australia, 56 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 12 SPI Pharma, 10 DKSH, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 4 Actylis, 2 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 7 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 6 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 36 Direct Compression, 29 Disintegrants & Superdisintegrants, 28 Thickeners and Stabilizers, 24 Lubricants & Glidants, 23 Granulation, 20 Coating Systems & Additives, 20 Co-Processed Excipients, 16 Film Formers & Plasticizers, 13 Controlled & Modified Release, 13 Taste Masking, 13 Solubilizers, 12 Parenteral, 8 Chewable & Orodispersible Aids, 8 Empty Capsules, 7 Topical, 6 Emulsifying Agents, 5 Rheology Modifiers, 3 API Stability Enhancers, 3 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 22 Finished Drug Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 88235 / DOSAGE - SYRUP;ORAL - 50MG/5ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ISONIAZID(UNII: V83O1VOZ8L) (ISONIAZID - UNII:V83O1VOZ8L)	ISONIAZID	50mg in 5

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC	Bryant Ranch Prepack	Mikart, LLC
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GLYCERIN(PDC6A3C0OX)
METHYLPARABEN(A2I8C7HI9T)
POTASSIUM SORBATE(1VPU26JZZ4)
PROPYLPARABEN(Z8IX2SC1OH)
SORBITOL(506T60A25R)

Drug Product Composition: Isoniazid

Isoniazid

Isoniazid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

7 USDMF

5 CEP/COS

1 JDMF

2 EU WC

5 NDC API

4 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

154 FDF Dossiers

61 FDA Orange Book

19 Europe

3 Canada

1 Australia

56 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

12 SPI Pharma

10 DKSH

6 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

14 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

4 Actylis

2 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

7 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

26 Kerry

1 Kima Chemical

3 Lonza Capsugel

18 Microlex e.U

1 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qualicaps

27 Roquette

2 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

12 Sigachi Industries

1 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

6 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders

36 Direct Compression

29 Disintegrants & Superdisintegrants

28 Thickeners and Stabilizers

24 Lubricants & Glidants

23 Granulation

20 Coating Systems & Additives

20 Co-Processed Excipients

16 Film Formers & Plasticizers

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons